Proton pump inhibitors and gastric neoplasia
- 1 September 2006
- Vol. 55 (9), 1217-1221
- https://doi.org/10.1136/gut.2005.090514
Abstract
Proton pump inhibitors (PPIs) are very effective in maintaining symptomatic and endoscopic remission of acid peptic disorders, such as gastro-oesophageal reflux disease. Side effects with respect to function and morphology of the gastric mucosa are common. Helicobacter pylori eradication can partially prevent and reverse these effects without impairing PPI therapy for gastro-oesophageal reflux disease. This makes long term PPI treatment a safe therapy for patients with acid peptic disorders. The potential side effects of such therapy are discussed here.Keywords
This publication has 41 references indexed in Scilit:
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- The Risk of Missed Gastroesophageal Cancer Diagnoses in Users and Nonusers of Antisecretory MedicationGastroenterology, 2005
- Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcomeAlimentary Pharmacology & Therapeutics, 2004
- Underutilization of preventive strategies in patients receiving NSAIDsRheumatology, 2003
- High-grade dysplasia in sporadic fundic gland polypsEuropean Journal of Gastroenterology & Hepatology, 2003
- Dysplasia in Fundic Gland Polyps is Associated with Nuclear β-Catenin Expression and Relatively High Cell Turnover RatesScandinavian Journal of Gastroenterology, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Prescription of Proton Pump Inhibitors Before Endoscopy: A Potential Cause of Missed Diagnosis of Early Gastric CancersArchives of Family Medicine, 2000
- Atrophic gastritis during long‐term omeprazole therapy affects serum vitamin B12 levelsAlimentary Pharmacology & Therapeutics, 1999
- Hypergastrinaemia during long‐term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1998